Assenagon Asset Management S.A. Sage Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $37.1 Billion
- Q1 2024
A detailed history of Assenagon Asset Management S.A. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 156,593 shares of SAGE stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
156,593
Previous 13,518
1058.4%
Holding current value
$1.66 Million
Previous $292,000
904.79%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$61.1 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$58.2 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$52 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$47.7 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $631M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...